Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study

Andrea Silvestrini, Elisabetta Meucci, Alvaro Mordente, Carmine Bruno, Angela Maria Rita Favuzzi, Nicola Nicolotti, Antonio Mancini

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Irisin, a recently discovered myokine, has been considered a prognostic factor in several cardiovascular diseases. Nevertheless, no data are available on the role of irisin in patients with heart failure (HF), both with preserved (HFpEF) or reduced (HFrEF) ejection fraction. We have therefore evaluated the circulating irisin levels in HFpEF and HFrEF patients, correlating them with metabolic parameters and total antioxidant capacity (TAC), as index of oxidative stress. Irisin was significantly higher in HFpEF than in HFrEF patients (7.72 ± 0.76 vs 2.77 ± 0.77 ng/ml, respectively). An inverse correlation between irisin and TAC was found in HFpEF, but not in HFrEF. Conversely, no correlation was present with HOMA index. These data support the hypothesis that a different pathophysiological mechanism is involved in the two HF subtypes, and oxidative stress modulates irisin secretion.
Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalPLoS One
DOIs
Publication statusPublished - 2019

Keywords

  • oxidative stress, heart failure

Fingerprint

Dive into the research topics of 'Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study'. Together they form a unique fingerprint.

Cite this